Schonfeld Strategic Advisors »

Contineum Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $217k 19k 11.75
2025-06-30 $652k 164k 3.97
2025-03-31 $993k 142k 6.98
2024-12-31 $1.8M 126k 14.65

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Ethereum Tr SHS (ETHA)
Fidelity Wise Origin Bitcoin SHS (FBTC)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
Alibaba Group Hldg Sponsored Ads (BABA)
Union Pacific Corporation (UNP)
Tesla Motors (TSLA)
Marvell Technology (MRVL)
Boston Scientific Corporation (BSX)

View all positions for Schonfeld Strategic Advisors

Top funds holding Contineum Therapeutics

RA Capital Management
Johnson & Johnson
Suvretta Capital Management
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Samsara BioCapital
Versant Venture Management
Point72 Asset Management

View all funds holding Contineum Therapeutics